DD

Deesha Dhanuka

Active Director Director DIN 11874016
DIN 11874016 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Deesha Dhanuka

Data last updated:

Deesha Dhanuka is a Director at Twenty4 Health Science Private Limited (since 2026) and Director/Designated Partner at Bluum Consumer Private Limited (since 2026).

DIN 11874016
Primary Designation Director
First Appointment 19 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20262026Active
Bluum Consumer Private Limited U56300MH2026PTC474401
Director/Designated Partner19 Aug 20262026Active

Board colleagues of Deesha Dhanuka

Directorship timeline

Open interactive timeline →
Bluum Consumer Private Limited
Twenty4 Health Science Private Limited
Premium access

Shareholding and investment profile for Deesha Dhanuka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deesha Dhanuka

Deesha Dhanuka currently holds 2 directorships: Twenty4 Health Science Private Limited (Director, since 20 Aug 2026); Bluum Consumer Private Limited (Director/Designated Partner, since 19 Aug 2026).

Deesha Dhanuka was first appointed on 19 Aug 2026 as Director/Designated Partner at Bluum Consumer Private Limited.

The current boards of Deesha Dhanuka's companies include Pawankumar Rajendra Bagga (Twenty4 Health Science Private Limited), Saurabh Mishra (Bluum Consumer Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available